Relationship Between Left Ventricular Structural and Metabolic Remodeling in Type 2 Diabetes
Adult
Male
Magnetic Resonance Spectroscopy
Phosphocreatine
Systole
Myocardium
Proton Magnetic Resonance Spectroscopy
Magnetic Resonance Imaging, Cine
Phosphorus Isotopes
Heart
Middle Aged
Coronary Angiography
3. Good health
03 medical and health sciences
Adenosine Triphosphate
0302 clinical medicine
Adipose Tissue
Diabetes Mellitus, Type 2
Echocardiography
Case-Control Studies
Humans
Female
Hypertrophy, Left Ventricular
DOI:
10.2337/db15-0627
Publication Date:
2015-10-06T02:58:18Z
AUTHORS (13)
ABSTRACT
Concentric left ventricular (LV) remodeling is associated with adverse cardiovascular events and is frequently observed in patients with type 2 diabetes mellitus (T2DM). Despite this, the cause of concentric remodeling in diabetes per se is unclear, but it may be related to cardiac steatosis and impaired myocardial energetics. Thus, we investigated the relationship between myocardial metabolic changes and LV remodeling in T2DM. Forty-six nonhypertensive patients with T2DM and 20 matched control subjects underwent cardiovascular magnetic resonance to assess LV remodeling (LV mass–to–LV end diastolic volume ratio), function, tissue characterization before and after contrast using T1 mapping, and 1H and 31P magnetic resonance spectroscopy for myocardial triglyceride content (MTG) and phosphocreatine-to-ATP ratio, respectively. When compared with BMI- and blood pressure–matched control subjects, subjects with diabetes were associated with concentric LV remodeling, higher MTG, impaired myocardial energetics, and impaired systolic strain indicating a subtle contractile dysfunction. Importantly, cardiac steatosis independently predicted concentric remodeling and systolic strain. Extracellular volume fraction was unchanged, indicating the absence of fibrosis. In conclusion, cardiac steatosis may contribute to concentric remodeling and contractile dysfunction of the LV in diabetes. Because cardiac steatosis is modifiable, strategies aimed at reducing MTG may be beneficial in reversing concentric remodeling and improving contractile function in the hearts of patients with diabetes.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (43)
CITATIONS (192)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....